Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,827Revenue $M309Net Margin (%)-36.0Altman Z-Score10.2
Enterprise Value $M4,577EPS $-0.9Operating Margin %-36.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.0Pre-tax Margin (%)-36.0Higher ROA y-yN
Price/Book26.910-y EBITDA Growth Rate %-4.9Quick Ratio2.3Cash flow > EarningsY
Price/Sales15.45-y EBITDA Growth Rate %-12.7Current Ratio2.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-24.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-53.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M125ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SGEN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
SGENVanguard Health Care Fund 2015-06-30 Buy 0.02%$34.03 - $49.63
$ 38.51-6%New holding170,125
SGENFirst Eagle Investment 2010-03-31 Sold Out -0.01%$9.34 - $12.59
$ 38.51255%Sold Out0
SGENFirst Eagle Investment 2009-12-31 Buy 0.01%$8.74 - $13.16
$ 38.51297%New holding67,373
SGENBill Gates 2009-09-30 Sold Out -0.39%$8.75 - $14.8
$ 38.51229%Sold Out0
SGENFirst Eagle Investment 2009-06-30 Sold Out -0.01%$8.18 - $10.34
$ 38.51324%Sold Out0
SGENFirst Eagle Investment 2009-03-31 Add$7.23 - $10.36
$ 38.51310%Add 40.00%70,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGEN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

SGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SIEGALL CLAY BPresident and CEO 2015-10-05Sell3,718$41.3-4.36view
BAKER FELIXDirector, 10% Owner 2015-09-15Buy5,159,484$42.56-7.19view
SIEGALL CLAY BPresident and CEO 2015-09-03Sell3,718$40.12-1.55view
SIEGALL CLAY BPresident and CEO 2015-08-20Sell31,754$42.02-6view
DOBMEIER ERICCOO 2015-08-20Sell8,548$42.02-6view
DRACHMAN JONATHAN GCMO & EVP, R & D 2015-08-20Sell4,462$42.02-6view
Cline Darren SSVP, Commercial 2015-08-20Sell2,231$42.02-6view
SIMPSON TODD ECFO 2015-08-20Sell5,825$42.02-6view
HIMES VAUGHN BEVP, Proc Svcs & Tech Ops 2015-08-20Sell5,997$42.02-6view
SIEGALL CLAY BPresident and CEO 2015-08-05Sell3,718$46.91-15.8view

Quarterly/Annual Reports about SGEN:

    News about SGEN:

    Articles On GuruFocus.com
    Insiders Are Buying Barnes & Noble Sep 18 2015 
    Vanguard Health Care Fund Buys Two New Stakes in Second Quarter Aug 06 2015 
    Insiders keep on buying Macerich Co and Seattle Genetics May 22 2015 
    Insiders new buys : ZU, SGEN, MAC, SHLD, TBRA May 12 2015 
    Seattle Genetics: Can Record Growth From Its Licenses Oct 28 2014 
    Seattle Genetics: Can Record Sustained Growth From Royalty Aug 31 2014 
    Will ImmunoGen’s Q4 Earnings Disappoint Again? Jul 30 2014 
    Weekly CFO Sells Highlight: USB, SGEN, CAH, ALXN, ABMD Jul 21 2013 
    Comment for Companies Ranked by Business Predictability Jan 03 2013 
    Weekly CFO Sells Highlight: SGEN, PFIE, MAR, ESRX, LIOX, RGEN Sep 10 2012 

    More From Other Websites
    8:03 am Seattle Genetics initiates a phase 1/2 clinical trial of Adcetris in combination with Opdivo... Oct 07 2015
    Seattle Genetics Announces Initiation of Phase 1/2 Clinical Trial of ADCETRIS® (Brentuximab... Oct 07 2015
    Seattle Genetics, Inc. Earnings Q2, 2015 Oct 02 2015
    Medivation and Bluebird Led IBB’s Mid-Cap Stocks Last Week Sep 29 2015
    Seattle Genetics: A Performance Overview Sep 28 2015
    Seattle Genetics Leads XBI Mid-Cap Stocks Sep 23 2015
    5 Stocks Insiders Love Right Now Sep 23 2015
    American Eagle Outfitters, Sears And Others That Insiders Have Been Buying Sep 23 2015
    XBI Moving Averages Are on the Rise Sep 22 2015
    Gigantic Biotech Trade Highlights The Week’s Insider Buying Sep 19 2015
    The Baker Brothers Are Bullish On Seattle Genetics And DBV Technologies Sep 16 2015
    Baker Bros. Relentlessly Adding Shares Of One Biotech, Going Activist On Another Sep 16 2015
    ETF’s with exposure to Seattle Genetics, Inc. : September 15, 2015 Sep 15 2015
    Seattle Genetics, Inc. breached its 50 day moving average in a Bullish Manner : September 15, 2015 Sep 15 2015
    Seattle Genetics (SGEN) Catches Eye: Stock Moves Up 8.3% Sep 14 2015
    Seattle Genetics Announces Exercise of Over-Allotment Option Sep 14 2015
    Seattle Genetics Announces Exercise of Over-Allotment Option Sep 14 2015
    SEATTLE GENETICS INC /WA Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Sep 11 2015
    Seattle Genetics Announces Pricing of Public Offering of Common Stock Sep 10 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)